Cathay Biotech Inc. (SHA:688065)

Cathay Biotech Revenue

Cathay Biotech had revenue of 937.72M CNY in the quarter ending September 30, 2026, with 7.26% growth. This brings the company's total for the last twelve months to 3.59B, up 9.13% year-over-year. In the year 2025, Cathay Biotech had annual revenue of 3.30B with 11.40% growth. That makes Cathay Biotech the 10,859th largest company in the world by revenue and 1,806th in China.

• Revenue (ttm): 3.59B
• Revenue Growth: +9.13%
• P/S Ratio: 7.84
• Revenue / Employee: 1.95M
• Employees: 1,844
• Market Cap: 28.13B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Biological Long-Chain Dibasic Acid 2.94B 94.1%
• Bio-Based Polyamide 127.41M 4.1%
• Others 57.84M 1.9%

By Geography

Chart

• China 2.18B 69.9%
• Overseas 938.57M 30.1%

Fiscal year ended Dec 31, 2025 See the full Cathay Biotech breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	3.30B	337.14M	11.40%
Dec 31, 2024	2.96B	843.74M	39.91%
Dec 31, 2023	2.11B	-326.93M	-13.39%
Dec 31, 2022	2.44B	77.62M	3.28%
Dec 31, 2021	2.36B	866.29M	57.86%

Data Source: S&P Global Market Intelligence Last updated: Oct 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 6, 2026

Data Sources Report a data error